NYQ·Healthcare·$667M·#72 / 520 in Healthcare
PHR Phreesia, Inc.
69SOLID
CATEGORY BREAKDOWN
GROWTH23
QUALITY74
STABILITY92
VALUATION98
GOVERNANCE55
METRIC BREAKDOWN
Revenue Growth (YoY)
Year-over-year revenue growth rate
+14.5%
23
> 50% strong
Gross Margin
Revenue retained after direct costs
67.9%
97
> 50% strong
Cash Runway
Months of cash at current burn rate
999 months
100
> 24 months ideal
Debt / Equity
Total debt relative to shareholder equity
30.4%
75
< 25% strong
Price / Sales
Market cap relative to trailing revenue
1.3x
98
< 3x strong
Rule of 40
Growth rate plus operating margin
13
40
> 40 excellent
Insider Ownership
Percentage of shares held by insiders
4.4%
35
> 20% strong
Share Dilution (12M)
Share count increase over last 12 months
+1.1%
94
< 5% ideal
SCORE HISTORY
RELATED STOCKS
COMPARE PHR WITH…
OR QUICK-COMPARE SECTOR PEERS
SCORE ALERT
Get notified when PHR's score changes by 5+ points.
DATA INFO
Last updated: Jul 1, 2026
Sources: SEC EDGAR, Financial Modeling Prep, Yahoo Finance. Not financial advice.